Emulate Company

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Technology: Organ-on-a-chip
Industry: AI for Longevity, Providers
Headquarters: Boston, Massachusetts, United States
Founded Date: 2013-01-01
Employees Number: 51-100
Funding Status: Late Stage Venture
Investors Number: 19
Total Funding: 224269991
Estimated Revenue: $10M to $50M
Last Funding Date: 2021-09-07
Last Funding Type: Series E

Visit Website
jenn.perkins@emulatebio.com
https://twitter.com/emulateinc
Register and Claim Ownership